N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial.

Autor: Merino A; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address: merin008@umn.edu., Brunstein CC; Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio., Shanley R; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Rashid F; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Wangen R; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Bachanova V; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Juckett M; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Maakaron J; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Felices M; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Weisdorf D; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Miller JS; Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Dec; Vol. 30 (12), pp. 1206.e1-1206.e12. Date of Electronic Publication: 2024 Oct 01.